On the contrary, they have failed to impact on cognition in individuals with mild–moderate Alzheimer’s disease carrying the ε4 allele of apolipoprotein E, an established risk factor for late-onset Alzheimer’s disease [119,120]. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.